clofibric acid has been researched along with Abnormalities, Drug-Induced in 1 studies
Clofibric Acid: An antilipemic agent that is the biologically active metabolite of CLOFIBRATE.
clofibric acid : A monocarboxylic acid that is isobutyric acid substituted at position 2 by a p-chlorophenoxy group. It is a metabolite of the drug clofibrate.
Abnormalities, Drug-Induced: Congenital abnormalities caused by medicinal substances or drugs of abuse given to or taken by the mother, or to which she is inadvertently exposed during the manufacture of such substances. The concept excludes abnormalities resulting from exposure to non-medicinal chemicals in the environment.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| de la Fuente, R | 1 |
| Santos, M | 1 |
1 other study available for clofibric acid and Abnormalities, Drug-Induced
| Article | Year |
|---|---|
[Toxicological and pharmacological studies on a new drug: pirfibrate (EL-466) (author's transl)].
Topics: Abnormalities, Drug-Induced; Animals; Clofibrate; Clofibric Acid; Diet, Atherogenic; Dogs; Female; F | 1980 |